CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $518 | – | 16,795 | +6618.0% | 0.08% | – |
| Q4 2022 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 250 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 250 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $3,000 | +200.0% | 250 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -75.0% | 250 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $4,000 | -42.9% | 250 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |